Category Archives: Email Alerts

It could get ugly

There’s a very old saying that’s all fair in love and war, but whoever said that never meet a pharmaceutical rep. Although there aren’t as many as there used to be reps can play a pivotal role when it comes

Posted in Email Alerts | Leave a comment

Are the inmates running the asylum?

While Livongo CEO Glen Tullman continues his fireside chat tour, the sharks are smelling blood in the water. The first shareholder lawsuit is underway and the stock after getting an initial boost from the Federal contract win, has begun to

Posted in Email Alerts | Leave a comment

Will Livongo be atoning for its sins?

On this day of atonement it could be Livongo that pays a heavy price for their sins. Per a press release issued yesterday; “Kaskela Law LLC is investigating Livongo Health, Inc. (“Livongo” or the “Company”) (NASDAQ:LVGO) on behalf of investors.

Posted in Email Alerts | Leave a comment

Resubmissions Approvals – What it all means

This morning Intarcia announced that the FDA has accepted the resubmission of their exenatide micropump. Per a company issued press release; “Intarcia Therapeutics, Inc., announced today that the U.S. Food and Drug Administration (FDA) has accepted the company’s resubmission of

Posted in Email Alerts | Leave a comment

The Problem and the burden

This morning Livongo issued a press release with the following headline; “Livongo Awarded Diabetes Contract for Eligible Population for Approximately 5.3 Million Beneficiaries Through the Federal Employees Health Benefits Program” While that sounds very impressive the headline illustrates the problem

Posted in Email Alerts | Leave a comment

A Preview of coming attractions

As we head full steam into the fourth quarter traditionally the strongest quarter for device sales, insulin pumps in particular news coming out of the Pacific Northwest isn’t promising. We recently reviewed the new reimbursement policy put out by Regence

Posted in Email Alerts | Leave a comment

The REAL story

On Tuesday Paul Hudson Sanofi’s new CEO told reporters; “It’s clear when I talk to people inside and outside the company [that] we can be more specific about what excites us in the pipeline. It’s a story that needs to

Posted in Email Alerts | Leave a comment

Say again please

Yesterday was an unusual day with Livongo actually going up while the markets were going down. Is this the long anticipated dead cat bounce or is this the start of climb back up? Only time will tell but one thing

Posted in Email Alerts | Leave a comment

Radio Silence

According to the S-1 Livongo filed before going public; “Our mission is to empower people with chronic conditions to live better and healthier lives.” The mission statement says nothing about how in the pursuit of this empowerment the company plans

Posted in Email Alerts | Leave a comment

End Game?

It looks as if our friends at Bigfoot have suffered another blow with the recent departure of their Vice President of Clinical and Medical Affairs who has moved onto greener pastures accepting a Medical Affairs and Research position at Apple.

Posted in Email Alerts | Leave a comment